Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1.22
MDSO's Cash to Debt is ranked lower than
73% of the 1740 Companies
in the Global Health Information Services industry.

( Industry Median: 21.46 vs. MDSO: 1.22 )
Ranked among companies with meaningful Cash to Debt only.
MDSO' s 10-Year Cash to Debt Range
Min: 0.4  Med: 109.61 Max: N/A
Current: 1.22
Equity to Asset 0.42
MDSO's Equity to Asset is ranked lower than
77% of the 1530 Companies
in the Global Health Information Services industry.

( Industry Median: 0.61 vs. MDSO: 0.42 )
Ranked among companies with meaningful Equity to Asset only.
MDSO' s 10-Year Equity to Asset Range
Min: -1.75  Med: 0.40 Max: 0.67
Current: 0.42
-1.75
0.67
Interest Coverage 1.31
MDSO's Interest Coverage is ranked lower than
96% of the 1126 Companies
in the Global Health Information Services industry.

( Industry Median: 10000.00 vs. MDSO: 1.31 )
Ranked among companies with meaningful Interest Coverage only.
MDSO' s 10-Year Interest Coverage Range
Min: 1.31  Med: 98.34 Max: 9999.99
Current: 1.31
1.31
9999.99
F-Score: 5
Z-Score: 6.07
M-Score: -2.92
WACC vs ROIC
15.21%
36.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 6.63
MDSO's Operating margin (%) is ranked higher than
57% of the 1708 Companies
in the Global Health Information Services industry.

( Industry Median: 5.04 vs. MDSO: 6.63 )
Ranked among companies with meaningful Operating margin (%) only.
MDSO' s 10-Year Operating margin (%) Range
Min: -36.17  Med: 7.44 Max: 14
Current: 6.63
-36.17
14
Net-margin (%) 2.30
MDSO's Net-margin (%) is ranked lower than
55% of the 1708 Companies
in the Global Health Information Services industry.

( Industry Median: 3.25 vs. MDSO: 2.30 )
Ranked among companies with meaningful Net-margin (%) only.
MDSO' s 10-Year Net-margin (%) Range
Min: -52.41  Med: 3.69 Max: 21.36
Current: 2.3
-52.41
21.36
ROE (%) 3.24
MDSO's ROE (%) is ranked lower than
58% of the 1668 Companies
in the Global Health Information Services industry.

( Industry Median: 6.12 vs. MDSO: 3.24 )
Ranked among companies with meaningful ROE (%) only.
MDSO' s 10-Year ROE (%) Range
Min: 2.48  Med: 14.64 Max: 63.95
Current: 3.24
2.48
63.95
ROA (%) 1.35
MDSO's ROA (%) is ranked lower than
58% of the 1748 Companies
in the Global Health Information Services industry.

( Industry Median: 3.11 vs. MDSO: 1.35 )
Ranked among companies with meaningful ROA (%) only.
MDSO' s 10-Year ROA (%) Range
Min: -106.4  Med: 4.46 Max: 22.66
Current: 1.35
-106.4
22.66
ROC (Joel Greenblatt) (%) 61.99
MDSO's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 1724 Companies
in the Global Health Information Services industry.

( Industry Median: 24.12 vs. MDSO: 61.99 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MDSO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -318.3  Med: 80.52 Max: 277.92
Current: 61.99
-318.3
277.92
Revenue Growth (3Y)(%) 17.50
MDSO's Revenue Growth (3Y)(%) is ranked higher than
81% of the 1298 Companies
in the Global Health Information Services industry.

( Industry Median: 5.10 vs. MDSO: 17.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MDSO' s 10-Year Revenue Growth (3Y)(%) Range
Min: -21.7  Med: 6.90 Max: 17.5
Current: 17.5
-21.7
17.5
EBITDA Growth (3Y)(%) -2.70
MDSO's EBITDA Growth (3Y)(%) is ranked lower than
65% of the 1047 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MDSO: -2.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MDSO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -4.15 Max: 14.7
Current: -2.7
0
14.7
EPS Growth (3Y)(%) -48.40
MDSO's EPS Growth (3Y)(%) is ranked lower than
91% of the 960 Companies
in the Global Health Information Services industry.

( Industry Median: 6.50 vs. MDSO: -48.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MDSO' s 10-Year EPS Growth (3Y)(%) Range
Min: -48.4  Med: -13.00 Max: 42.9
Current: -48.4
-48.4
42.9
» MDSO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

MDSO Guru Trades in Q2 2014

Frank Sands 4,720,008 sh (New)
George Soros 126,666 sh (New)
Columbia Wanger 1,360,500 sh (+105.36%)
Chuck Royce 40,000 sh (unchged)
Steven Cohen 47,400 sh (unchged)
Jim Simons Sold Out
Ron Baron 230,635 sh (-55.48%)
» More
Q3 2014

MDSO Guru Trades in Q3 2014

Columbia Wanger 1,793,500 sh (+31.83%)
Frank Sands 4,866,217 sh (+3.10%)
Chuck Royce 40,000 sh (unchged)
Steven Cohen Sold Out
Ron Baron 193,346 sh (-16.17%)
George Soros 6,666 sh (-94.74%)
» More
Q4 2014

MDSO Guru Trades in Q4 2014

Jim Simons 5,494 sh (New)
Columbia Wanger 1,999,800 sh (+11.50%)
Frank Sands 5,126,077 sh (+5.34%)
Frank Sands 5,126,077 sh (+5.34%)
Chuck Royce 40,000 sh (unchged)
George Soros Sold Out
Ron Baron 189,579 sh (-1.95%)
» More
Q1 2015

MDSO Guru Trades in Q1 2015

Joel Greenblatt 19,844 sh (New)
Chuck Royce 166,765 sh (+316.91%)
Frank Sands 5,399,777 sh (+5.34%)
Columbia Wanger 2,008,800 sh (+0.45%)
Jim Simons Sold Out
Ron Baron 147,353 sh (-22.27%)
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 389.20
MDSO's P/E(ttm) is ranked lower than
97% of the 1089 Companies
in the Global Health Information Services industry.

( Industry Median: 25.20 vs. MDSO: 389.20 )
Ranked among companies with meaningful P/E(ttm) only.
MDSO' s 10-Year P/E(ttm) Range
Min: 11.44  Med: 65.62 Max: 2448.5
Current: 389.2
11.44
2448.5
Forward P/E 44.44
MDSO's Forward P/E is ranked lower than
80% of the 530 Companies
in the Global Health Information Services industry.

( Industry Median: 19.61 vs. MDSO: 44.44 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 383.60
MDSO's PE(NRI) is ranked lower than
96% of the 1084 Companies
in the Global Health Information Services industry.

( Industry Median: 25.00 vs. MDSO: 383.60 )
Ranked among companies with meaningful PE(NRI) only.
MDSO' s 10-Year PE(NRI) Range
Min: 11.53  Med: 61.83 Max: 2448.5
Current: 383.6
11.53
2448.5
P/B 10.92
MDSO's P/B is ranked lower than
89% of the 1616 Companies
in the Global Health Information Services industry.

( Industry Median: 2.69 vs. MDSO: 10.92 )
Ranked among companies with meaningful P/B only.
MDSO' s 10-Year P/B Range
Min: 4.53  Med: 10.65 Max: 28.83
Current: 10.92
4.53
28.83
P/S 8.47
MDSO's P/S is ranked lower than
84% of the 1692 Companies
in the Global Health Information Services industry.

( Industry Median: 2.19 vs. MDSO: 8.47 )
Ranked among companies with meaningful P/S only.
MDSO' s 10-Year P/S Range
Min: 1.31  Med: 3.93 Max: 12.62
Current: 8.47
1.31
12.62
PFCF 40.69
MDSO's PFCF is ranked lower than
69% of the 806 Companies
in the Global Health Information Services industry.

( Industry Median: 25.46 vs. MDSO: 40.69 )
Ranked among companies with meaningful PFCF only.
MDSO' s 10-Year PFCF Range
Min: 12.91  Med: 55.93 Max: 276.85
Current: 40.69
12.91
276.85
POCF 35.10
MDSO's POCF is ranked lower than
75% of the 1008 Companies
in the Global Health Information Services industry.

( Industry Median: 18.25 vs. MDSO: 35.10 )
Ranked among companies with meaningful POCF only.
MDSO' s 10-Year POCF Range
Min: 10.42  Med: 37.82 Max: 133.3
Current: 35.1
10.42
133.3
EV-to-EBIT 115.93
MDSO's EV-to-EBIT is ranked lower than
89% of the 1150 Companies
in the Global Health Information Services industry.

( Industry Median: 16.85 vs. MDSO: 115.93 )
Ranked among companies with meaningful EV-to-EBIT only.
MDSO' s 10-Year EV-to-EBIT Range
Min: 8.8  Med: 43.20 Max: 381.8
Current: 115.93
8.8
381.8
PEG 201.89
MDSO's PEG is ranked lower than
99% of the 479 Companies
in the Global Health Information Services industry.

( Industry Median: 1.85 vs. MDSO: 201.89 )
Ranked among companies with meaningful PEG only.
MDSO' s 10-Year PEG Range
Min: 7.91  Med: 42.04 Max: 209.64
Current: 201.89
7.91
209.64
Shiller P/E 137.52
MDSO's Shiller P/E is ranked lower than
91% of the 685 Companies
in the Global Health Information Services industry.

( Industry Median: 30.78 vs. MDSO: 137.52 )
Ranked among companies with meaningful Shiller P/E only.
MDSO' s 10-Year Shiller P/E Range
Min: 110.05  Med: 206.30 Max: 6000
Current: 137.52
110.05
6000
Current Ratio 3.68
MDSO's Current Ratio is ranked higher than
76% of the 1574 Companies
in the Global Health Information Services industry.

( Industry Median: 2.08 vs. MDSO: 3.68 )
Ranked among companies with meaningful Current Ratio only.
MDSO' s 10-Year Current Ratio Range
Min: 0.44  Med: 2.08 Max: 5.35
Current: 3.68
0.44
5.35
Quick Ratio 3.68
MDSO's Quick Ratio is ranked higher than
77% of the 1574 Companies
in the Global Health Information Services industry.

( Industry Median: 1.94 vs. MDSO: 3.68 )
Ranked among companies with meaningful Quick Ratio only.
MDSO' s 10-Year Quick Ratio Range
Min: 0.44  Med: 2.08 Max: 5.35
Current: 3.68
0.44
5.35
Days Sales Outstanding 83.59
MDSO's Days Sales Outstanding is ranked lower than
63% of the 1474 Companies
in the Global Health Information Services industry.

( Industry Median: 68.77 vs. MDSO: 83.59 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDSO' s 10-Year Days Sales Outstanding Range
Min: 45.45  Med: 72.70 Max: 90.9
Current: 83.59
45.45
90.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 134.28
MDSO's Price/Net Current Asset Value is ranked lower than
98% of the 1006 Companies
in the Global Health Information Services industry.

( Industry Median: 6.74 vs. MDSO: 134.28 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MDSO' s 10-Year Price/Net Current Asset Value Range
Min: 8.65  Med: 15.80 Max: 4775
Current: 134.28
8.65
4775
Price/Tangible Book 11.80
MDSO's Price/Tangible Book is ranked lower than
80% of the 1378 Companies
in the Global Health Information Services industry.

( Industry Median: 4.05 vs. MDSO: 11.80 )
Ranked among companies with meaningful Price/Tangible Book only.
MDSO' s 10-Year Price/Tangible Book Range
Min: 6.32  Med: 11.15 Max: 151.5
Current: 11.8
6.32
151.5
Price/Projected FCF 5.80
MDSO's Price/Projected FCF is ranked lower than
84% of the 784 Companies
in the Global Health Information Services industry.

( Industry Median: 1.75 vs. MDSO: 5.80 )
Ranked among companies with meaningful Price/Projected FCF only.
MDSO' s 10-Year Price/Projected FCF Range
Min: 4.95  Med: 6.90 Max: 10.1
Current: 5.8
4.95
10.1
Price/Median PS Value 2.17
MDSO's Price/Median PS Value is ranked lower than
84% of the 1521 Companies
in the Global Health Information Services industry.

( Industry Median: 1.19 vs. MDSO: 2.17 )
Ranked among companies with meaningful Price/Median PS Value only.
MDSO' s 10-Year Price/Median PS Value Range
Min: 0.34  Med: 1.00 Max: 3.02
Current: 2.17
0.34
3.02
Price/Graham Number 13.88
MDSO's Price/Graham Number is ranked lower than
95% of the 835 Companies
in the Global Health Information Services industry.

( Industry Median: 2.18 vs. MDSO: 13.88 )
Ranked among companies with meaningful Price/Graham Number only.
MDSO' s 10-Year Price/Graham Number Range
Min: 1.91  Med: 6.92 Max: 29.93
Current: 13.88
1.91
29.93
Earnings Yield (Greenblatt) (%) 0.90
MDSO's Earnings Yield (Greenblatt) (%) is ranked lower than
60% of the 1684 Companies
in the Global Health Information Services industry.

( Industry Median: 2.70 vs. MDSO: 0.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDSO' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.3  Med: 2.30 Max: 11.3
Current: 0.9
0.3
11.3
Forward Rate of Return (Yacktman) (%) -3.77
MDSO's Forward Rate of Return (Yacktman) (%) is ranked lower than
79% of the 664 Companies
in the Global Health Information Services industry.

( Industry Median: 11.09 vs. MDSO: -3.77 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDSO' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -3.8  Med: 0.90 Max: 21.2
Current: -3.77
-3.8
21.2

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:2M9.Germany,
Medidata Solutions Inc was incorporated in June 1999and reincorporated in the State of Delaware in May 2000. The Company is a provider of cloud-based solutions for clinical research in life sciences, designed to transform clinical development and increase the value of the customers' research investments. Medidata's solutions are designed to address the underlying requirements of clinical development, rather than just its current processes, to maximize the value of the overall research process. Its cloud-based solutions, metrics and services allow users to accurately and efficiently design clinical trials; manage and monitor ongoing trial activities; develop and administer trial budgets; capture, manage and report clinical trial data; plan and execute randomized subject allocation methodologies; manage and allocate clinical trial supplies; and view, track, and evaluate trial progress through easy-to-use, Internet-enabled platforms. The Company compete with firms such as Oracle, Perceptive Informatics and others offering products and services that compete with one or more of the solutions. It competes on the basis of several factors, including, breadth and depth of solution offerings; platform capabilities, including interoperability; ease of use of solutions and rates of user adoption; solution functionality and flexibility; analytics and benchmarking; speed and performance required to enable customers to access clinical trial data in real-time; product reliability and scalability; infrastructure accessibility and security; regulatory compliance; financial stability; commercial and technology partnerships; depth of expertise and quality of professional services and customer support on a global basis; and sales and marketing capabilities, including the ability to create and communicate operational value. The Company has registered trademarks and service marks in the United States and abroad, and filed applications for the registration of additional trademarks and service marks. The principal trademarks are "Medidata," "Medidata Clinical Cloud," "Medidata Patient Cloud," "Medidata CRO Contractor," "Medidata Designer," "Medidata Grants Manager," "Medidata Rave," "Medidata Balance," "Medidata Coder," and "Medidata Insights." It also holds several domain names, including the domain names "mdsol.com" and "medidatasolutions.com". The use of Company's software products, services and hosted solutions by customers engaged in clinical trials must be done in a manner that is compliant with a complex array of United States federal and state laws and regulations, including regulation by the Food and Drug Administration, as well as regulations and guidance issued by foreign governments and international non-governmental organizations.
» More Articles for MDSO

Headlines

Articles On GuruFocus.com
Medidata: SaaS Business Model Leveraging Growth Of The Company Oct 23 2014 
Frank Sands Adds 5 New Stocks Aug 14 2014 
Medidata Solutions: Benefit from Growing Cloud Applications with This Stock May 27 2014 
Medidata Solutions : A SAAS Provider For Your Portfolio Mar 23 2014 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares Mar 08 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,000 Shares Mar 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Feb 07 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Feb 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Jan 10 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Jan 05 2011 

More From Other Websites
Medidata Cloud-Based Clinical Research Solution in Demand - Analyst Blog Jun 25 2015
Japanese Biotech JCR Pharmaceuticals Selects Medidata's Cloud-Based Platform to Power Rare Disease... Jun 24 2015
Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform to Power Rare Disease... Jun 24 2015
Japanese Biotech JCR Pharmaceuticals Selects Medidata’s Cloud-Based Platform to Power Rare Disease... Jun 24 2015
Edited Transcript of MDSO presentation 13-May-15 6:30pm GMT Jun 17 2015
Medidata Completes Study Exploring Potential for Instrumenting Patients with Mobile Health Tools in... Jun 15 2015
Medidata Completes Study Exploring Potential for Instrumenting Patients with Mobile Health Tools in... Jun 15 2015
Full-Service CRO PROMETRIKA Expands Use of Medidata’s Cloud-Based Platform to Drive Cutting-Edge... Jun 11 2015
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 29 2015
MEDIDATA SOLUTIONS, INC. Financials May 20 2015
Medidata to Present at 43rd Annual J.P. Morgan Global Technology, Media & Telecom Conference May 15 2015
Medidata to Present at 43rd Annual J.P. Morgan Global Technology, Media & Telecom Conference May 15 2015
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers May 14 2015
Medidata's Kara Dennis Named an Industry "Rising Star" by the Healthcare Businesswomen's Association May 14 2015
Medidata’s Kara Dennis Named an Industry “Rising Star” by the Healthcare Businesswomen’s... May 14 2015
10-Q for Medidata Solutions, Inc. May 13 2015
Medidata to Present at Jefferies 2015 Global Technology, Media & Telecom Conference May 06 2015
Medidata to Present at Jefferies 2015 Global Technology, Media & Telecom Conference May 06 2015
Medidata Unveils Open-Source Connector Linking Apple® ResearchKitTM to the Medidata Clinical... May 05 2015
Medidata Unveils Open-Source Connector Linking Apple® ResearchKitTM to the Medidata Clinical... May 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK